PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Clover Health Investments, Corp. (CLOV)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS18914F1030
SectorHealthcare
IndustryHealthcare Plans

Highlights

Market Cap$314.81M
EPS-$0.44
Revenue (TTM)$2.04B
Gross Profit (TTM)$126.19M
EBITDA (TTM)-$186.08M
Year Range$0.61 - $1.63
Target Price$1.44
Short %10.91%
Short Ratio3.23

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Clover Health Investments, Corp.

Popular comparisons: CLOV vs. AMC

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Clover Health Investments, Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%NovemberDecember2024FebruaryMarchApril
-29.43%
22.02%
CLOV (Clover Health Investments, Corp.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Clover Health Investments, Corp. had a return of -29.63% year-to-date (YTD) and -7.92% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-29.63%5.84%
1 month-14.18%-2.98%
6 months-29.47%22.02%
1 year-7.92%24.47%
5 years (annualized)N/A11.44%
10 years (annualized)N/A10.46%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20240.64%-9.84%-8.09%
2023-17.56%-11.73%-3.39%3.38%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of CLOV is 44, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of CLOV is 4444
Clover Health Investments, Corp.(CLOV)
The Sharpe Ratio Rank of CLOV is 4343Sharpe Ratio Rank
The Sortino Ratio Rank of CLOV is 4646Sortino Ratio Rank
The Omega Ratio Rank of CLOV is 4545Omega Ratio Rank
The Calmar Ratio Rank of CLOV is 4444Calmar Ratio Rank
The Martin Ratio Rank of CLOV is 4444Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


CLOV
Sharpe ratio
The chart of Sharpe ratio for CLOV, currently valued at -0.12, compared to the broader market-2.00-1.000.001.002.003.004.00-0.12
Sortino ratio
The chart of Sortino ratio for CLOV, currently valued at 0.34, compared to the broader market-4.00-2.000.002.004.006.000.34
Omega ratio
The chart of Omega ratio for CLOV, currently valued at 1.04, compared to the broader market0.501.001.501.04
Calmar ratio
The chart of Calmar ratio for CLOV, currently valued at -0.09, compared to the broader market0.002.004.006.00-0.09
Martin ratio
The chart of Martin ratio for CLOV, currently valued at -0.25, compared to the broader market0.0010.0020.0030.00-0.25
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.05, compared to the broader market-2.00-1.000.001.002.003.004.002.05
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.98, compared to the broader market-4.00-2.000.002.004.006.002.98
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.002.004.006.001.55
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.05, compared to the broader market0.0010.0020.0030.008.05

Sharpe Ratio

The current Clover Health Investments, Corp. Sharpe ratio is -0.12. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.12
2.05
CLOV (Clover Health Investments, Corp.)
Benchmark (^GSPC)

Dividends

Dividend History


Clover Health Investments, Corp. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-96.98%
-3.92%
CLOV (Clover Health Investments, Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Clover Health Investments, Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Clover Health Investments, Corp. was 97.19%, occurring on Apr 17, 2024. The portfolio has not yet recovered.

The current Clover Health Investments, Corp. drawdown is 96.98%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.19%Jun 9, 2021719Apr 17, 2024
-60.05%Dec 29, 202096May 17, 202115Jun 8, 2021111
-24.35%Sep 30, 202032Nov 12, 202026Dec 21, 202058
-7.48%Jul 13, 202029Aug 20, 202015Sep 11, 202044
-7.25%Sep 21, 20204Sep 24, 20203Sep 29, 20207

Volatility

Volatility Chart

The current Clover Health Investments, Corp. volatility is 12.31%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%NovemberDecember2024FebruaryMarchApril
12.31%
3.60%
CLOV (Clover Health Investments, Corp.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Clover Health Investments, Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items